Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements  by Mostert, Jeanette C. et al.
European Neuropsychopharmacology (2015) 25, 2062–2074http://dx.doi.org/1
0924-977X/& 2015 E
nCorresponding au
Netherlands.
E-mail address: b
1These authors cowww.elsevier.com/locate/euroneuroCognitive heterogeneity in adult attention
deﬁcit/hyperactivity disorder: A systematic
analysis of neuropsychological measurements
Jeanette C. Mosterta,b,1, A. Marten H. Onninkc,1, Marieke Kleina,
Janneke Dammersa,c, Anais Harneita, Theresa Schultena,
Kimm J.E. van Hulzena,b, Cornelis C. Kanc,
Dorine Slaats-Willemsed, Jan K. Buitelaard,e,
Barbara Frankea,c,n,1, Martine Hoogmana,1aDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands
bDonders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour,
Radboud University, Nijmegen, The Netherlands
cDepartment of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University
Medical Center, Nijmegen, The Netherlands
dKarakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands
eDepartment of Cognitive Neurosciences, Donders Institute for Brain, Cognition and Behaviour, Radboud
University Medical Center, Nijmegen, The NetherlandsReceived 29 December 2014; received in revised form 3 August 2015; accepted 13 August 2015KEYWORDS
Adult ADHD;
Neuropsychology;
Heterogeneity;
Executive function;
Reward;
Reaction time
variability0.1016/j.euroneur
lsevier B.V. and E
thor at: Departme
arbara.franke@ra
ntributed equally.Abstract
Attention Deﬁcit/Hyperactivity Disorder (ADHD) in childhood is associated with impaired
functioning in multiple cognitive domains: executive functioning (EF), reward and timing.
Similar impairments have been described for adults with persistent ADHD, but an extensive
investigation of neuropsychological functioning in a large sample of adult patients is currently
lacking. We systematically examined neuropsychological performance on tasks measuring EF,
delay discounting, time estimation and response variability using univariate ANCOVA’s compar-
ing patients with persistent ADHD (N=133, 42% male, mean age 36) and healthy adults (N=132,
40% male, mean age 36). In addition, we tested which combination of variables provided the
highest accuracy in predicting ADHD diagnosis. We also estimated for each individual the
severity of neuropsychological dysfunctioning. Lastly, we investigated potential effects of
stimulant medication and a history of comorbid major depressive disorder (MDD) on perfor-
mance. Compared to healthy adults, patients with ADHD showed impaired EF, were moreo.2015.08.010
CNP. All rights reserved.
nt of Human Genetics (855), Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, The
dboudumc.nl (B. Franke).
2063Cognitive heterogeneity in adult attention deﬁcit/hyperactivity disorder: A systematic analysisimpulsive, and more variable in responding. However, effect sizes were small to moderate
(range: 0.05–0.70) and 11% of patients did not show neuropsychological dysfunctioning. The
best ﬁtting model predicting ADHD included measures from distinct cognitive domains (82.1%
speciﬁcity, 64.9% sensitivity). Furthermore, patients receiving stimulant medication or with a
history of MDD were not distinctively impaired. To conclude, while adults with ADHD as a group
are impaired on several cognitive domains, the results conﬁrm that adult ADHD is neuropsy-
chologically heterogeneous. This provides a starting point to investigate individual differences
in terms of impaired cognitive pathways.
& 2015 Elsevier B.V. and ECNP. All rights reserved.1. Introduction
Attention Deﬁcit/Hyperactivity Disorder (ADHD) is a common
and highly heritable neuropsychiatric disorder in childhood that
is strongly persistent over time. At least 35% of all childhood
patients still meet full ADHD criteria in adulthood (American
Psychiatric Association, 2000), and this percentage is much
higher (78%) when partial remitted patients are included
(Biederman et al., 2010). ADHD has an average prevalence of
2.5–4.9% in the adult population (Simon et al., 2009). The
clinical phenotype of ADHD is characterized by persistent, age-
inappropriate symptoms of inattention, and/or hyperactivity
and impulsivity (American Psychiatric Association, 2000).
ADHD has been associated with neurocognitive dysfunction-
ing, and over the years, several neuropsychological theories
about ADHD etiology have been put forward. One of the most
inﬂuential theories proposed ADHD to arise from a single core
deﬁcit in behavioral inhibition, which leads to secondary
impairments in several executive functions (Barkley, 1997).
However, this assumption of a central deﬁcit was challenged
by data showing that ADHD patients are impaired in multiple
neuropsychological domains. It has therefore been proposed
that there are distinct pathways to dysfunction, including
executive function (EF) deﬁcits, delay aversion, and timing
problems (Castellanos et al., 2006; Sonuga-Barke et al., 2010).
Although not included in the multiple pathway model, another
characteristic of ADHD is performance variability. The incon-
sistency in performance and the high prevalence of moment-to-
moment variability in reaction times is one of the most
consistently reported manifestations of ADHD. Reaction time
variability (RTV) received extensive discussion as an indicator of
cognitive performance, although the exact nature of high RTV in
ADHD is still uncertain (Koﬂer et al., 2013; Tamm et al., 2012).
Studies of cognitive functioning in adults with ADHD suggest
that cognitive impairments found in adults resemble those
observed in children with ADHD, showing equally moderate
effects sizes (for meta-analytic reviews, see Boonstra et al.,
2005; Hervey et al., 2004; Schoechlin and Engel, 2005).
Similar results were derived from qualitative reviews
(Seidman, 2006; Woods et al., 2002). Recent meta-analyses
in adult ADHD focused solely on deﬁcits found in working
memory (Alderson et al., 2013) and long-term memory
(Skodzik et al., 2013). Furthermore, recent experimental
studies on adult ADHD show deﬁcits in attention (Fuermaier
et al., 2015; Grane et al., 2014), set-shiﬁting (Boonstra et al.,
2010; Halleland et al., 2012; Rohlf et al., 2012) inhibition(Boonstra et al., 2010; Fuermaier et al., 2015), (working)
memory (Fuermaier et al., 2015; Lundervold et al., 2015;
Rohlf et al., 2012), delay discounting (Marx et al., 2010), and
increased reaction time variability (Feige et al., 2013;
Gmehlin et al., 2014; Grane et al., 2014).
From the childhood literature, we know that ADHD is
characterized by large heterogeneity at the neuropsycho-
logical level, which means that only a minority of ADHD
patients shows deﬁcits in each domain and that some
patients with ADHD will perform in the normal range
(Nigg et al., 2005b). Such heterogeneity was illustrated
in a recent study on boys with ADHD (Coghill et al., 2013).
Per cognitive domain merely 18–36% of the patients had an
impairment, while 25% of the sample did not show deﬁ-
cient performance in any of the cognitive domains.
Heterogeneity in cognitive performance within a sample
of ADHD patients may also arise from differences in
medication use or comorbidity. Stimulants are effective
for the treatment of clinical symptoms in adult ADHD
(Faraone et al., 2004) and also in neuropsychological
studies medication is usually seen as a potential modera-
tor. Many neuropsychological studies in ADHD have
included patients who had previously taken, or were
receiving stimulant medication at the time of the study.
To eliminate the acute effects of medication, most studies
used a washout period (24 h or 48 h). However, stimulants
may act longer than 48 h (McCarthy et al., 2014). Simi-
larly, ADHD patients with a comorbid psychiatric disorder
showed greater neuropsychological deﬁcits than ADHD
patients without comorbidity (Hervey et al., 2004) and
may represent a distinct subgroup, with different cogni-
tive proﬁles (Fischer et al., 2007). However, it has also
been shown that cognitive deﬁcits in adult ADHD cannot
be accounted for by comorbid disorders (Nigg et al.,
2005a; Silva et al., 2013). Major depressive disorder
(MDD) is the most frequently observed comorbidity, and
can co-occur with ADHD in up to 50% of the cases (Wilens
et al., 2009). MDD has been associated with cognitive
difﬁculties in memory, attention and problem–solving.
Only two studies examined comorbid MDD in ADHD to
date, both suggesting that current comorbid MDD symp-
toms may not inﬂuence neuropsychological proﬁles in
ADHD (Katz et al., 1998; Riordan et al., 1999). While
potential effects of comorbid MDD on cognition are often
controlled for by excluding patients with current MDD
from a study, many included patients will have remitted
MDD. It is currently not known whether adult ADHD
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on cognitive performance, although it has been shown that
ADHD symptom severity increases in association with life-
time occurrence of comorbid MDD (Simon et al., 2013).
Reviewing the literature of adult ADHD shows that experi-
mental studies and meta-analyses are limited by relying on
relatively small samples with different inclusion criteria and
tasks. Those studies had limited power to investigate con-
founding effects on neuropsychological functioning such as
comorbidity or treatment. Also, the investigation of different
tasks or functions in different samples has limited the possibi-
lity to construct a comprehensive picture of impairments
associated with adult ADHD. To improve conﬁdence in the
ﬁndings, replication/validation in a large cohort of adult ADHD
patients is thus desirable. Lastly, except for studies by Seidman
et al. (1998), Boonstra et al. (2010), and Fuermaier et al.
(2015), most studies assessed only a narrow range of neurop-
sychological tasks. Therefore, we investigated case-control
differences on a wide range of well-described neuropsycholo-
gical tasks using the largest sample of adult ADHD patients to
date. Neuropsychological tasks were chosen based on the
multiple pathway model and RTV literature described above
and measured motor speed, sustained attention, inhibition,
delay discounting, time estimation, set-shifting, verbal ﬂuency,
working memory, and response variability. We expected effect
sizes to be moderate, with strongest effects on RTV as this is a
pervasive characteristic observable across tasks (Koﬂer et al.,
2013). Furthermore, we were interested in the diagnostic
relevance of these tasks. From a clinical perspective it is
interesting to know the predictive importance of neuropsycho-
logical measurements in ADHD classiﬁcation. Previous literature
showed however that neuropsychological measurements have a
relatively poor ability to discriminate between children with
ADHD and typically developing controls (Sjowall et al., 2013) or
adults with ADHD and psychiatric patients without ADHD (Holst
and Thorell, 2013). It remains an open question how discrimi-
native the investigated neuropsychological tasks are in a
sample of healthy adults with and without ADHD. We further
investigated heterogeneity in performance and severity by
computing the number of deﬁcient test scores per participant
as was previously done in childhood ADHD (Coghill et al., 2013).
Additionally, we explored the potential effect of stimulant
medication and a history of comorbid MDD on performance.2. Experimental procedures
2.1. Participants
The study population was the Dutch cohort of the International
Multicenter persistent ADHD CollaboraTion (IMpACT—http://impac
tadhdgenomics.com (Franke et al., 2010)). This is an ongoing study
that at the time of analysis (1 January 2014) included 298 partici
pants (155 adult ADHD cases, 143 healthy comparison participants).
Patients and healthy control participants were recruited at the
department of Psychiatry of the Radboud university medical center
in Nijmegen and through advertisements. Patients were included if
they had previously been diagnosed with persistent ADHD, i.e.
present since childhood, by a psychiatrist according to the Diagnostic
and Statistical Manual of Mental Disorders (4th edition; DSM-IV-TR;
American Psychiatric Association, 2000). Exclusion criteria for parti
cipants were psychosis, alcohol or substance addiction in the last sixmonths, current major depression, full-scale IQ estimate o70,
neurological disorders, sensorimotor disabilities, non-Caucasian eth
nicity, medication use other than psychostimulants, atomoxetine or
bupropion and failure to withhold stimulant medication 24 h prior to
testing (see Section 2.2). Additional exclusion criteria for healthy
controls were a current or lifetime neurological or psychiatric
disorder in either the proband or his/her ﬁrst-degree relatives. From
the total sample, 33 participants (22 patients, 11 controls) had to be
excluded because they met at least one of these exclusion criteria
(see Supplementary Table 1).
This study was approved by the regional ethics committee
(Centrale Commissie Mensgebonden Onderzoek: CMO Regio Arn-
hem—Nijmegen; Protocol number III.04.0403). Written informed
consent was obtained from all participants.
2.2. Procedure
Subjects were invited for two sessions (Supplementary Fig. 1), one
including a detailed psychiatric assessment and blood withdrawal
for biobanking of DNA, RNA and serum. A second session consisted
of cognitive testing and neuroimaging procedures. The genetic and
neuroimaging data are described elsewhere (i.e. Franke et al.,
2010; Hoogman et al., 2011). For session 2, participants were
requested to withhold stimulant medication 24 h prior to testing.
2.3. Psychiatric assessment
Both patients and controls were assessed using the structured
Diagnostic Interview for ADHD in Adults (DIVA (Kooij, 2010)). This
interview focuses on the 18 DSM-IV symptoms of ADHD and uses
concrete and realistic examples to thoroughly investigate whether a
symptom is currently present or was present in childhood. In
addition, a self-report questionnaire on current symptoms was
obtained using the ADHD Rating Scale-IV (Kooij et al., 2005). The
Dutch version of the Structured Clinical Interview for DSM-IV, SCID-I
and SCID-II (Groenestijn et al., 1999; Weertman et al., 2000) was
used to identify lifetime Axis I and II disorders. Twenty-two patients
and 12 controls did not participate in the clinical interview. These
participants were included in the main analysis based on a prior
diagnosis of ADHD by a psychiatrist and if they reached clinical
threshold for ADHD based on the self-report scale. They were
excluded from the analysis of comorbidity (see below).
2.4. Neuropsychological measurements
The neuropsychological test battery included measures tapping into EF
(working memory, attention, inhibition, set-shifting, verbal ﬂuency),
delay discounting, and time estimation. Details about tasks and main
outcome measures are described in Table 1 and the supplementary
text. To estimate IQ, Vocabulary and Block Design of the Wechsler Adult
Intelligence Scale (WAIS-III) were administered (Wechsler, 1997). The
tests were always administered in the same order.
2.5. Data analysis of neuropsychological tasks
All measures were entered as raw scores in the analyses. Performance on
each neuropsychological measure was entered as the dependent variable
in separate univariate ANCOVA’s, testing the difference between patients
and controls. Age and gender were entered as covariates of no interest
in order to reduce error variance (Miller and Chapman, 2001). This was
justiﬁed as age and gender did not differ between the groups. We
therefore also did not investigate interactions between diagnosis and
age or gender. As IQ is correlated with performance on many neurop-
sychological tasks, we investigated whether adding estimated IQ as an
additional covariate would inﬂuence the ﬁndings. As IQ also did not
Table 1 Tasks and outcome measures of the neuropsychological test battery.
Task Task descriptionn Cognitive
domain
Outcome measure
1. Baseline
speed task
Participants respond with a button press as
quickly as possible when a ﬁxation cross
changes into a block-shape
Motor speed &
reaction time
Mean RT
SD of RT
2. WAIS-III Digit
span task
Participants repeat strings of digits that are
read aloud by the experimenter. In the
backward condition, strings are repeated in
reverse order. Each trial the working memory
load increases
Executive
functioning:
Working memory
Forward digit span score
Backward digit span score
3. Flanker task Participants respond with a button press to
the color of the center block (yellow or blue),
ﬂanked by other blocks. In part 1, the center
block is ﬂanked by blocks of the same color
(congruent trial) or a different color (green,
neutral trial). In part 2, the neutral trials are
replaced by incongruent trials (ﬂanking blocks
with the color of the alternative response)
Executive
functioning:
Inhibition
Total mean RT (average over part 1 and
2)
Total SD of RT (average over part 1 and 2)
Inhibition RT (difference in RT on
congruent and incongruent trials in part
2)
Inhibition errors (difference in error rate
between congruent and incongruent
trials in part 2)
4. Sustained
attention dots
task (SA-dots)
Three, four or ﬁve dots are presented on the
screen. Participants respond with a button
press with the dominant hand to four dots and
with the non-dominant hand to three or ﬁve
dots. An erroneous button press to three or
ﬁve dots is a false alarm; an erroneous button
press to four dots is a miss. For analysis, the
task is split up into ten blocks, or series, in
order to compute variance in performance
over time. The duration of task is 20 min
Executive
functioning:
Attention &
inhibition
Mean series completion time
SD series completion time
SD series errors (SD of the errors made
across blocks)
Response bias (the difference between
the number of misses and the number of
false alarms across the entire task)
5. Sustained
Attention to
Response Task
(SART)
Go/No-Go task. Participants respond with a
button press to single digits presented on the
screen (1–9), but to withhold a response when
the digit 3 is presented
Executive
functioning:
Attention &
inhibition
Number of commission errors
Number of omission errors
Mean RT hits
SD of RT hits
6. Trailmaking
task
Participants need to connect dots containing
numbers in consecutive order (part A) or
alternating between numbers and letters in
consecutive order (part B)
Executive
functioning:
Motor control &
set-shifting
Time to complete part A
Time to complete part B
Difference in time to complete part B
and time to complete part A
7. Semantic
category and
initial letter
ﬂuency
Participants name as many animals or
professions they can think of in 1 min. Next,
they name as many words starting with a ‘D’,
‘A’ or ‘T’ as they can think of in 1 min
Executive
functioning:
Verbal ﬂuency
Number of words mentioned in category
animals
Number of words mentioned in category
professions
Number of words mentioned in category
letters (total of 3 letter-trials)
8. Delay
discounting
task
Participants repeatedly have to choose
between two hypothetical incentives that
differ in the value (money) and delay (time
until the money would be received). The
impulsivity parameter (k) is computed from
the present value of the delayed reward (V),
the real value of the delayed reward (a) and
the delay in days (D) with the formula: V=a/
(1+kD)
Delay aversion &
impulsivity
K 100 (impulsivity high rewards)
K 30 (impulsivity intermediate rewards)
K 10 (impulsivity low rewards)
9. Time
estimation
task
Participants have to respond with a button
press exactly one second after hearing a
sound beep. First, during a training session
the length of a second is shown several times.
During the experiment, feedback is given
(‘too slow’, ‘correct’, ‘too fast’)
Timing Median response time
Absolute deviation of the median
response time from 1000 ms
RT=reaction time; SD=standard deviation; ms=milliseconds.
nMore detailed information about the tasks, including references, can be found in Supplementary materials.
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Table 2 Demographics (N=265a).
Healthy controls (N=132) ADHD patients (N=133) p-
Value
Gender 53 (40.2%) male 56 (42.1%) male n.s.
Age 36.30 (11.75), range 19–63 35.56 (10.40), range 18–59 n.s.
Estimated IQb 109.97 (14.90) 107.83 (14.28) n.s.
Educationc 5.16 (0.81), range 3–7 4.70 (0.80), range 2–7 o0.001
Repeated school years (once or
more)
53 (40.2%) 77 (57.9%) 0.005
Non-completed education
programs (one or more)
40 (33.3%) (N=128) 87 (67.4%) (N=129) o0.001
Handedness 115 (87.1 %) right, 13 (9.8%) left, 3 (2.3%)
ambidextrous (N=131)
113 (85%) right, 16 (12%) left, 4
(3%) ambidextrous
n.s.
Inattentive symptoms (DIVA) 0.39 (0. 83), 0–4 (N=120) 7.38 (1.55), 3–9 (N=112) o0.001
Hyperactive/impulsive symptoms
(DIVA)
0.52 (0.98), 0–4 (N=120) 5.76 (2.27), 0–9 (N=112) o0.001
Total symptoms (DIVA) 0.91 (1.43), 0–8 (N=120) 13.14 (2.76), 7–18 (N=112) o0.001
Inattentive symptoms (selfreport) 0.53 (0.98), 0–5 (N=131) 6.40 (2.09), 0–9 o0.001
Hyperactive/impulsive symptoms
(selfreport)
0.89 (1.44), 0–6 (N=131) 5.58 (2.26), 0–9 o0.001
Total symptoms (selfreport) 1.42 (2.14) 0–9 (N=131) 11.98 (3.37), 1–18 o0.001
Data show as: mean (standard deviation), minimum–maximum. p-values represent the signiﬁcance of the group difference, tested
with independent samples t-tests for continuous data or Pearson Chi-square tests for categorical data;
a32 subjects from the total sample were excluded from analyses according to our exclusion criteria.
bIQ was estimated based on performance on the WAIS-III block pattern and vocabulary tasks.
cEducation level was coded from 1 (unﬁnished primary school) to 7 (post-university).
dDIVA interview data was missing for 22 patients.
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not serve to control for IQ. Assumptions with respect to the residuals
were checked and neuropsychological measures were transformed if
necessary. Outliers were deﬁned as having a score more extreme than
four times the standard deviation above or below the mean per group
(Leth-Steensen et al., 2000; Nigg et al., 2005a). This threshold guarded
against artifacts and chance level performance, while still including
cases performing at the extreme of the normal distribution. If a
participant’s score was an outlier on one outcome variable of a task,
his/her scores on all outcome variables from that task were excluded.
Effect sizes were computed as Cohen’s D, using the corrected means
from the ANCOVA’s (Cohen, 1988).
Multiple comparison correction was performed by estimating the
effective number of independent tests (Meff) (Li and Ji, 2005). This
method takes into account the correlation structure between measures
and calculates the Meff based on the observed eigenvalue variance of
the different neuropsychological measures using the matSpD interface
(http://genepi.qimr.edu.au/general/daleN/matSpD). The p-value for
signiﬁcance was determined as 0.05 divided by Meff. Twenty-seven
measures resulted in twenty-two independent tests and therefore, only
effects with a p-value o0.0023 were considered signiﬁcant.
Second, to investigate discriminating ability of the neuropsycho-
logical test battery, we used a step-wise backward logistic regres-
sion model. To maximize power, with our sample size, we included
only those neuropsychological measures that were nominally sig-
niﬁcant in the case-control comparison to determine the model
with the highest prediction accuracy of diagnostic status. Variables
were retained in the model when they signiﬁcantly contributed to
the likelihood ratio statistic, all other variables were excluded.
To investigate heterogeneity in cognitive impairments, we com-
puted the number of deﬁcient test scores for each participant. Similar
to previous studies, a deﬁcient score was deﬁned as performance
below the 10th percentile of the performance distribution of thecontrol group (Coghill et al., 2013; Nigg et al., 2005b). For variables
where higher scores indicated worse performance, deﬁciency was
deﬁned as a score above the 90th percentile of performance
distribution of the control group. For the variable ‘time estimation
median response time’ performance at both lower and upper extreme
was scored as deﬁcient. As not all participants had completed data
for all tasks, we computed the relative number of deﬁcient test
scores as a percentage of the total number of scores for that
participant. We labeled between 1% and 20% deﬁcient test scores
as ‘mildly impaired’, between 20% and 40% as ‘impaired’ and above
40% as ‘severely impaired’. The difference between cases and
controls in the number of relative deﬁcient test scores was computed
using an ANCOVA with age and gender as covariates. In addition, we
repeated the same analysis in a restricted group of only those
participants with complete data (N=168).
2.6. Effects of stimulant medication and history of MDD
We conducted two exploratory analyses. First, in order to investi-
gate stimulant medication effects on neuropsychological measures,
we used separate ANCOVA’s for each neuropsychological measure
comparing medication naïve patients (N=20), medicated patients
(N=83), and healthy control participants (N=132), with age and
gender as covariates. Second, we conducted a similar analysis
comparing patients with at least one lifetime MDD episode (now
in remission, N=55), patients without a history of MDD (N=68), and
healthy controls without prior episodes of MDD (N=112). Twenty
healthy control participants reported to have experienced depres-
sive episodes in the past and were therefore excluded from this
analysis. For both analyses, in the case of a main effect of group on
the neuropsychological measure, we tested post-hoc the differ-
ences between groups. These post-hoc tests were Bonferroni
corrected for multiple testing.
Table 3 Case/control analysis of cognitive performance (N=265).
NPO Task Variable Healthy
Controls
ADHD ANCOVA Effect
size
Mean (SD) Mean (SD) F (df), p-value Cohen’s
D
1. Digit span test HC:
N=132 ADHD:
N=128
Forward score 9.83 (2.36) 8.99 (1.95) 10.45 (1, 256), p=0.001n 0.40
Backward score 7.49 (2.34) 6.69 (2.22) 8.62 (1, 256), p=0.004 0.37
2. Baseline speed
(ANT) HC: N=130
ADHD: N=129
Mean RT 313.28 (49.42) 316.83 (55.29) 0.40 (1, 255), n.s. 0.07
SD of RT† 4.08 (0.53) 4.26 (0.57) 7.47 (1, 255), p=0.007 0.34
3. Flanker task (ANT)
HC: N =127 ADHD:
N=123
Total mean RT 525.37 (73.00) 537.93 (92.87) 1.85 (1, 246), n.s. 0.18
Total SD of RT 93.74 (37.04) 118.39 (58.87) 15.90 (1, 246), p o0.001n 0.51
Inhibition RT 28.44 (28.25) 23.13 (40.76) 1.45 (1, 246), n.s. 0.14
Inhibition errors 0.68 (1.48) 0.63 (1.47) 0.11 (1, 246), n.s. 0.05
4. SAdots (ANT) HC: N
=128 ADHD: N=123
Mean series completion
time
899.05 (129.21) 944.71 (186.08) 5.03 (1, 247), P=0.026 0.28
SD completion time† 3.81 (0.44) 4.07 (0.53) 16.82 (1, 247), p o0.001n 0.52
SD errors† 0.70 (0.19) 0.86 (0.26) 32.03 (1, 247), p o0.001n 0.71
Response bias 5.05 (6.10) 9.16 (9.51) 18.35 (1, 247), p o0.001n 0.52
5. SART HC: N=110
ADHD: N=104
Commission errors 9.31 (5.03) 10.51 (4.87) 3.02 (1, 210), n.s. 0.25
Omission errors 2.63 (3.57) 4.04 (4.97) 5.72 (1, 210), p=0.018 0.32
Mean RT hits 315.50 (57.48) 326.09 (60.74) 2.44 (1, 210), n.s. 0.21
SD or RT† 4.35 (0.36) 4.56 (0.44) 14.17 (1, 210), p o0.001n 0.53
6. Fluency HC: N=132
ADHD: N=131
Category; animals 27.76 (5.77) 25.85 (5.97) 6.84 (1, 259), p=0.009 0.32
Category: professions 20.27 (5.23) 19.81 (5.09) 0.48 (1, 259), n.s. 0.10
Letters 41.91 (10.51) 38.95 (10.87) 5.15 (1, 259), p=0.024 0.29
7. Time estimation HC:
N=126 ADHD:
N=116
Median response time 1007.09 (67.61) 997.94 (82.21) 1.13 (1, 238), n.s. 0.14
Absolute deviation of the
median response time from
1000 ms
49.38 (46.38) 63.92 (51.40) 5.49 (1, 238), p=0.020 0.30
8. Delay Discounting
HC: N=123 ADHD:
N=109
K 100† 5.25 (1.54) 4.50 (1.65) 12.85 (1, 228), p o0.001n 0.48
K 30† 4.76 (1.65) 4.38 (1.66) 3.15 (1, 228), n.s. 0.23
K 10† 4.39 (1.43) 3.97 (1.67) 4.43 (1, 228), p=0.036 0.27
9. Trailmaking task
HC: N=132 ADHD:
N=128
Part A 23.70 (7.51) 26.80 (8.24) 11.60 (1, 256), p=0.001n 0.43
Part B 50.06 (17.30) 57.89 (20.30) 12.50 (1, 254), p o0.001n 0.44
Part B–A 26.33 (13.51) 31.00 (18.38) 5.88 (1, 254), p=0.016 0.30
ANCOVA testing the effect of group for each neuropsychological measure, with age and gender as covariates.
†Log-transformed variable to a normal distribution.
nIndicates p-values surviving correction for the effective number of independent tests conducted (N=22, signiﬁcance threshold
(type 1 error rate at 5%)=0.0023) (Li and Ji, 2005).
2067Cognitive heterogeneity in adult attention deﬁcit/hyperactivity disorder: A systematic analysis3. Results
3.1. Demographics
A total of 265 participants (132 healthy controls and 133 ADHD
patients) were included in the analyses. Demographic informa-
tion is provided in Table 2. Patients and controls did not differ in
age, handedness, and estimated IQ. Gender was equally
distributed across groups. Patients had received fewer years of
education than controls. As expected, patients had signiﬁcantly
more ADHD symptoms based on the diagnostic interview and
self-report. Information about psychiatric comorbidities and
medication is summarized in Supplementary Tables 2 and 3.3.2. Effect of diagnosis on cognitive performance
Findings from the case-control comparison of neuropsycho-
logical performance are summarized in Table 3 and dis-
played in (Fig. 1). In the domain of EF patients were
impaired on working memory and attention, but no group
differences were found for inhibition (Flanker and SART
task) and verbal ﬂuency. In the domain of delay aversion
patients performed worse than controls on the delay
discounting task, but not in the domain of timing (time
estimation task). Across several tasks, patients were also
more variable in their reaction times than controls.
Fig. 1 Differences in performance between ADHD patients and controls on measurements from several cognitive domains.
Bar graphs indicate the average performance per group for each neuropsychological measure (time estimation absolute median deviation
from 1000 ms is not shown); error bars represent the standard error of the mean. Dark grey bars represent the healthy control group,
lighter grey bars represent ADHD patient group. An asterix (*) indicates measures where patients differed signiﬁcantly from controls.
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in most tasks, except for both conditions of the Trailmaking
tasks. Effect sizes were in the small to medium range, with
the largest effect on the SA-dots task where patients
showed more ﬂuctuation in errors across blocks (effect
size=0.71). Adding the covariate IQ, in addition to age
and gender, did not signiﬁcantly alter the results.
3.3. Variables predicting ADHD diagnosis
A stepwise backwards logistic regression identiﬁed six out of 17
variables to signiﬁcantly contribute to a model predicting
diagnosis: Digit span (forward), Flanker (total SD of RT), SAdots
(SD series errors and response bias), Delay discounting (k100)
and Time estimation (absolute median deviation from
1000 ms). The entire model signiﬁcantly distinguished patients
from controls (Log-likelihood=174.13, R2 (Nagelkerke)=0.39,
χ2=57.54 (6 df), po0.001) and had a sensitivity (correctlypredicting patients) of 64.9% and a speciﬁcity (correctly
predicting controls) of 82.1%. Model details are shown in
Supplementary Table 4.
3.4. Number of deﬁcient test scores across all
outcome measures
Patients had deﬁcient test scores on a signiﬁcant larger
proportion of variables than controls (mean controls=9.16%
(SD=9.23), mean ADHD=15.82% (SD=13.55), F=22.34 (1,
261), po0.001). This effect remained when only including
participants with complete data (F=13.08 (1, 164),
po0.001). As apparent from Fig. 2, there was a large
variability between individual patients, with some patients
not having any deﬁcient scores (11%), while others were
severely impaired (5%). The majority (62%) of patients was
mildly impaired, and 23% was impaired. This variability was
also present in the control group, although here the
Fig. 2 Deﬁcient test scores across participants.
For each participant, deﬁcient test scores were computed as the number of test scores that were below the score of the bottom 10%
of the control group, divided by the total number of test scores of that participant and multiplied with 100%. The sections indicate
the percentage of participants that had a deﬁcient test score within a certain bin. ‘Mildly impaired’ are participants with 1–20%
deﬁcient test scores, ‘impaired’ are those with 20–40% deﬁcient test scores and those with more than 40% deﬁcient were labeled as
‘severely impaired’.
2069Cognitive heterogeneity in adult attention deﬁcit/hyperactivity disorder: A systematic analysismajority of participants (64%) had deﬁcient scores on 10% or
less of the outcome variables.
3.5. Effects of stimulant medication and history
of MDD on neuropsychological measures
We additionally investigated the effect of stimulant medication
on neuropsychological performance by comparing medication
naïve patients, medicated patients and controls. Group effects
where all in the same direction as in the main case-control
analysis, although smaller (Supplementary Table 5). Post-hoc
comparisons indicated that on the time estimation task
medication naïve patients responded faster than medicated
patients and controls.
The main effects from the case-control analyses were
also reproduced when comparing healthy controls to ADHD
patients with and without a history of MDD (Supplementary
Table 6). On none of the neuropsychological measures did
patients with a history of MDD differ from patients without
this comorbidity. However, on several measures patients
with a history of MDD did not differ from controls and
patients without MDD, despite a main effect of group.
4. Discussion
In this study we examined the neuropsychological performance
of a large group of patients with persistent ADHD and healthy
adult control participants on a broad range of neuropsycholo-
gical tasks. As a group, patients with ADHD showed impaired
EF, especially working memory and sustained attention, were
more sensitive to delay aversion, and had increased response
variability as compared to healthy controls. Stepwise logistic
regression analysis showed that measures from distinct cogni-
tive domains collectively contributed to the predictive model
explaining variance in ADHD. Despite this, the model had
limited predictive power for diagnostic status. Cognitive
heterogeneity of the sample was also apparent from large
inter-individual variability in the number of deﬁcient test
scores, especially in the ADHD group, but also in controls.
Strikingly, no case-control differences were found in tasks
measuring inhibition and timing in our test battery. Effectsizes were small to moderate, and medication and a history of
MDD comorbidity did not explain differences in performance in
adult ADHD.
As described, a popular model of childhood ADHD implicates
three neuropsychological pathways in childhood ADHD, one
involving EF deﬁcits, one involving altered reward processing,
and one involving temporal processing deﬁcits (Castellanos
et al., 2006; Sonuga-Barke et al., 2010). We report evidence
for impairment in EF and reward processing, but not in
temporal processing in patients with persistent ADHD. Our
ﬁnding that EF deﬁcits are primarily related to working
memory and sustained attention is in agreement with the
adult ADHD literature (Boonstra et al., 2005; Hervey et al.,
2004). This result stresses the signiﬁcance of attentional
problems in adult ADHD and may reﬂect the fact that the
symptoms of hyperactivity and impulsivity decrease as ADHD
children approach adulthood (Biederman et al., 2000). It has
been suggested that IQ may play a role in explaining working
memory and attention deﬁcits in adult ADHD (Boonstra et al.,
2010; Murphy et al., 2001). However, as the groups did not
differ on IQ, and covarying for IQ did not alter the results, this
explanation is unlikely.
Contrary to expectations, we did not ﬁnd EF differences
related to inhibition, set-shifting, or verbal ﬂuency. The
ability to inhibit a response has been posited as a core
domain impaired in ADHD (Barkley, 1997), and has been
found in several studies of adult ADHD (Boonstra et al.,
2005, 2010; Hervey et al., 2004), though not in others
(Gmehlin et al., 2014; Halleland et al., 2012). We used the
SART and Flanker tasks to measure inhibition, but are
cautious to interpret our null ﬁndings as strong evidence
against inhibition deﬁcits in adult ADHD. First, the Flanker
task showed a ceiling effect in inhibition errors, which is
consistent with ﬁndings in early adolescence (Drechsler
et al., 2005; Harms et al., 2014). This task may therefore
lack sensitivity to measure inhibition impairments in adult
ADHD. Second, on the SART, the number of commission
errors (measuring inhibition) did not differ between
patients and controls, nor did the number of omission errors
(measuring attention). To better characterize inhibition
deﬁcits in adult ADHD, a more sensitive measure would be
the stop signal reaction time as measured with a stop signal
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stimulus intervals often at a rapid pace that requires
participants to interrupt an already ongoing response. This
task design may provoke impulsive responses among parti-
cipants more strongly and may thus be more sensitive to
inhibition problems in ADHD (Epstein et al., 2001). Indeed,
manipulation of response prepotency was effective in
evoking response inhibition difﬁculties in adult ADHD
patients (Grane et al., 2014).
Set-shifting is another component of EF, which we
measured using part B of the Trailmaking task. Even though
patients were slower on this part of the task, they were
equally slow on part A, which measures motor speed (Nigg
et al., 2005a). This ﬁnding is in line with other studies in
adult ADHD suggesting that deﬁcits in set-shifting are
explained by impaired processing speed (Rohlf et al.,
2012). We thus conclude that set-shifting as measured with
the Trailmaking task was not impaired in the adult ADHD
group. Lastly, patients did not differ from controls in verbal
ﬂuency measures, which contradicts previous ﬁndings
(Boonstra et al., 2005; Hervey et al., 2004). This could be
due to the good IQ-matching between patients and controls
in our sample, whereas in other studies patients had lower
IQ than controls. In children it was found that IQ signiﬁ-
cantly correlated with verbal ﬂuency (Ardila et al., 2000).
Hence, previously reported differences in verbal ﬂuency
may be more attributable to differences in IQ than to ADHD.
Delay aversion may represent a second neuropsychologi-
cal pathway towards ADHD, linked to altered processing of
rewards (Sonuga-Barke, 2002). Our results of stronger delay
discounting in patients are in line with other evidence of
increased impulsive decision making in persistent ADHD
(Paloyelis et al., 2009; Marx et al., 2010). The tendency
to prefer immediate (smaller) over delayed (larger) rewards
is also considered to be an aspect of impulsivity potentially
important for the development of substance use disorders
(Dick et al., 2010). Therefore, stronger delay aversion might
represent a vulnerability marker for substance abuse in
ADHD (Bickel et al., 2012). A third pathway involves
temporal processing deﬁcits (Sonuga-Barke et al., 2010).
In the present study, patients did not differ from controls on
timing accuracy using a time estimation task with an
interval of one second. These ﬁndings are supported by a
recent study using the same task, which showed deﬁcits in
time estimation accuracy were present in adolescents with
ADHD, but not in adults (Thissen et al., 2014). However,
another study, which examined time estimation in adults
with ADHD using several time intervals (2, 6, 12, 24, 36 and
48 s), found that the patients produced errors predomi-
nantly at interval durations of 36 and 48 s (Marx et al.,
2010). This may suggest that tasks using an interval of one
second may not be sensitive enough to measure existing
timing deﬁcits in adult ADHD.
In the analyses comparing patients and controls the largest
effect sizes were observed for measures of performance
variability, both in terms of ﬂuctuations in errors as in reaction
times. This conﬁrms our hypothesis, which was based on
previous studies identifying RTV as one of the most robust
features of ADHD (Koﬂer et al., 2013; Tamm et al., 2012).
Notably, the average reaction time on the tasks used to
measure RTV did not differ between patients and controls,
supporting the notion that RTV is not attributable todifferences in processing speed (Koﬂer et al., 2013). Rather,
RTV is thought to reﬂect lapses in attention that produce a
skewed reaction time distribution with a large tail (Leth-
Steensen et al., 2000). More thorough investigation of RTV
used ex-Gaussian modeling and showed that increased RTV is
partly due to overly slow responses (Feige et al., 2013;
Gmehlin et al., 2014; Wolfers et al., 2015). These slow
responses are reﬂected by the ex-Gaussian parameter tau,
which represents the exponential component of the reaction
time distribution. Recently, we showed that the tau parameter
was associated with the microstructural integrity of the right
superior longitudinal fasciculus, a white matter tract impli-
cated in both attention and ADHD (Wolfers et al., 2015). Taken
together, such ﬁndings suggest a neurobiological basis for
within-subject variability in ADHD. Interestingly, we observed
the largest effect size for the variance in errors made during
the SA-dots task. This is a promising novel measure for future
studies on sustained attention in ADHD using a continuous
performance task.
We achieved limited accuracy in predicting ADHD diag-
nosis from neuropsychological performance, despite the
large number of cognitive test variables available. This is
consistent with what was previously found in children with
ADHD (Sjowall et al., 2013). The best ﬁtting predictive
model included six measures from different cognitive
domains (EF, response variability, timing and delay aversion)
and reached 82.1% speciﬁcity and 64.9% sensitivity. This
rather low sensitivity makes a test based on cognitive
measures insufﬁcient as a diagnostic tool for ADHD in
clinical practice. The variables retained in the ﬁnal model
of the logistic regression could be inﬂuenced by outliers, as
these can be expected to contribute strongly to the model.
However, all extreme outliers were removed from the data
before data analysis, reducing the effect of erroneous data
on the model. Rather, the variables in the model are likely
to be most sensitive to behavioral impairments associated
with ADHD, as was also reﬂected in the effect sizes of most
of these variables in the case-control analysis. Importantly,
measures from distinct cognitive domains collectively con-
tributed to the model, indicating that there is not a single
cognitive task or domain sufﬁcient for explaining ADHD on
the group level. This is in agreement with the theory of
multiple pathways leading to impairment in ADHD (Sonuga-
Barke et al., 2010). Besides that heterogeneity can be
explained by impairments in multiple cognitive pathways,
we also observed differences in severity of impairments
between individuals. The majority of patients were
impaired on less than 20% of all cognitive measures, and
while a small proportion of patients had more than 40%
deﬁcient test scores, 11% of patients did not show any
deﬁcit. This is in line with studies in childhood ADHD
(Coghill et al., 2013; Nigg et al., 2005b; Sonuga-Barke
et al., 2010). Importantly, only 23% of our healthy control
participants did not show any deﬁcits, which is much lower
than the previously reported 53% and 60% (Coghill et al.,
2013; Nigg et al., 2005b). However, these differences
between studies can be explained by the fact that the
current study included many more variables (27 instead of
four and six). Furthermore, the majority of controls fell in
the ‘mildly impaired’ group, which means they performed
deﬁciently on 1–20% of the tasks. Seeing that the criterion
for having a deﬁcient test score was performing at the
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that controls perform deﬁciently on some tasks.
The current ﬁndings provide a starting point to investigate
individual differences in terms of impaired cognitive path-
ways, for instance by using clustering analyses on the neu-
ropsychological data (Fair et al., 2012). Such an approach
follows the recently proposed strategy by the NIMH, called
Research Domain Criteria (RDoC) to investigate mental dis-
orders in a dimensional instead of categorical manner (http://
www.nimh.nih.gov/research-priorities/rdoc/index.shtml). Ne-
urocognitive measures can be used to characterize psycho
pathology without being restricted to current disorder cate
gories. This will aid in the understanding of the neurobiological
and behavioral underpinnings of mental disorders. Further
more, neuropsychological investigations may be helpful for
clinicians in characterizing individual differences, allowing
more personalized treatments.
We did not ﬁnd evidence for subgroups within the patient
group, neither due to stimulant medication treatment nor
history of comorbid MDD, which could explain the observed
cognitive heterogeneity. Medication use did not inﬂuence
task performance in our exploratory analysis; medication
naïve patients performed similar to medicated patients.
Mechanisms linking pharmacological actions of stimulants to
neuropsychological processes are speculative, although our
results support observations that, in adult ADHD, stimulants
seem to produce little improvement on a variety of neu-
ropsychological tasks (Advokat, 2010; Turner et al., 2005).
Similarly, the group of patients with a comorbidity in the
form of a history of MDD did not seem to differ greatly from
the group without this comorbidity in terms of neuropsy-
chological functioning. This extends earlier ﬁndings and
suggest that ADHD patients diagnosed with current or
remitted MDD show similar neuropsychological proﬁles as
patients diagnosed with ADHD alone (Katz et al., 1998;
Riordan et al., 1999). It should be noted however that this
study was not set up to investigate the effects of stimulant
medication or differences between patients with and with-
out a history of comorbid MDD, hence these effects should
be investigate further.
The ﬁndings presented here should be considered in light
of several strengths and weaknesses. This study is unique in
its large, well-deﬁned naturalistic sample of patients and a
well-matched control sample. We have used a large battery
of tasks covering EF, timing, and delay aversion domains.
This allows our ﬁndings to be interpreted on the scale of
cognitive domains instead of on a task-speciﬁc level. Our
sample was large enough to investigate effects of (at least
one) comorbidity. However, our investigation of the effect
of stimulant medication was likely underpowered as there
were only 20 medication naïve patients in our sample.
Investigating the effects of stimulant medication in adults
is challenging, as by deﬁnition these patients have been
symptomatic for a long period. It would therefore be more
relevant to investigate the effect of medication duration
across patients, but this requires well-documented medica-
tion use history, which was not available. Additionally, our
ﬁndings are limited by the tasks included in our testing
battery. We did not include measures tapping into the
domains of planning or decision making, which are also
important in ADHD psychopathology. Furthermore, our
measures of time estimation could be improved by havinglonger timing intervals. Similarly, inhibition could be mea-
sured by computing stop-signal reaction times from a stop
signal task. Including such measures might improve the
predictive power for diagnostic status.
To conclude, our study provides novel insights into adult
ADHD neuropsychology as well as conﬁrmation of ﬁndings
observed in earlier, smaller studies. In summary, our study
adds to the literature in the following ways: (1) compared
with previous studies, our sample size is almost two
(Seidman et al., 1998) or three times larger (Boonstra
et al., 2010; Fuermaier et al., 2015); (2) we also examined
delay aversion and timing deﬁcits which was not sufﬁ-
ciently covered by previous work; (3) while other studies
investigated variability in reaction times only, we also
investigated variability in errors made during a continuous
performance task; (4) we investigated confounding effects
of depression history and stimulant treatment (the ADHD
patient samples from Seidman et al. (1998) and Boonstra
et al. (2010) were all medication-naïve); (5) ours was the
ﬁrst study in adult ADHD to calculate the number of
deﬁcient test scores per participant as was previously
done in childhood ADHD (Coghill et al., 2013); (6) we
studied not only simple group differences but also mea-
sures of sensitivity and speciﬁcity to examine the discri-
minatory ability of the neuropsychological test battery in
adult ADHD. Our comprehensive analysis of cognitive
performance in a large sample of patients with persistent
ADHD and well-matched healthy control participants con-
ﬁrms that several cognitive domains are affected in the
adult ADHD population, with moderate effect sizes. Both
the ADHD and the control sample were heterogeneous in
their cognitive performance, with large differences in the
number of tasks on which participants scored deﬁcient. In
line with this, a predictive model including measures from
several domains had limited power to predict diagnostic
status. Neuropsychological tasks may therefore be more
relevant for characterizing individual impairments that can
speciﬁcally be targeted with personalized treatment.
Future studies focusing on inter-individual differences in
performance of patients may aid in a better understanding
of ADHD etiology and its persistence, also in terms of the
underlying biology.Financial support
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